APOA2 encodes apolipoprotein A-II, a major component of HDL particles. Its primary role is in lipid metabolism, not directly in blood sugar regulation. Some population-based studies (e.g., GWAS) have reported associations between certain APOA2 variants and fasting glucose or insulin resistance, but effect sizes are small and findings inconsistent. Mechanistically, APOA2 might indirectly influence glucose homeostasis through modulation of HDL subclasses or inflammatory pathways. However, the evidence is largely exploratory and insufficient for clinical recommendations. Direct-to-consumer DNA tests that include APOA2 variants often overstate clinical relevance. Blood sugar screening or dietary changes should not be based solely on APOA2 genotypes. Caveat: The predictive value of such tests is limited; lifestyle factors and other genes have a much larger impact on blood sugar.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-be868955f91f9ff88b2e55f5